![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1562278
¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¿Ü·¡ ¼¾Æ®·² Ç®ÇÊ¸ÕÆ® ½ÃÀå ¿¹Ãø(-2030³â) : Áö¿ªº° ºÐ¼® - Á¦Ç° À¯Çüº°, ÃÖÁ¾»ç¿ëÀÚº°Asia Pacific Outpatient Central Fulfillment Market Forecast to 2030 - Regional Analysis - by Product Type and End User |
¾Æ½Ã¾ÆÅÂÆò¾ç ¿Ü·¡ ¼¾Æ®·² Ç®ÇÊ¸ÕÆ® ½ÃÀåÀº 2022³â 5,060¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç, 2030³â¿¡´Â 1¾ï 2,644¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2022³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ 12.1%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.
°í·ÉÈ Àα¸ Áõ°¡¿Í ½ÅÈï ½ÃÀåÀ¸·Î ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¿Ü·¡ ¼¾Æ®·² Ç®ÇÊ¸ÕÆ® ½ÃÀå ¼ºÀå ÃËÁø
°í·ÉÈ´Â ÇコÄÉ¾î ºÐ¾ß ¹ßÀüÀÇ ¿¼è¸¦ Áã°í ÀÖ½À´Ï´Ù. µû¶ó¼ °í·ÉÈ Àα¸ÀÇ Áõ°¡´Â ¾à±¹¿¡ Áß¿äÇÑ ¼ºÀå ±âȸ°¡ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. À¯¿£ÀÇ 'World Population Prospects 2022' º¸°í¼¿¡ µû¸£¸é ³ëÀÎ Àα¸´Â 2022³â Àüü Àα¸ÀÇ 10%¿¡¼ 2050³â 16%±îÁö Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. °í·ÉÈ Àα¸°¡ ºü¸£°Ô Áõ°¡ÇÔ¿¡ µû¶ó ³ëÀÎ Äɾî¿Í ÀǾàǰ¿¡ ´ëÇÑ ¼ö¿ä´Â ¾ÕÀ¸·Î ºñ¾àÀûÀ¸·Î Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Àü ¼¼°è Æò±Õ ¼ö¸íÀÇ Áõ°¡´Â ³ëÀÎ Äɾ ´ëÇÑ µðÁöÅÐÈ ¹× ÀÚµ¿È ½Ã½ºÅÛÀÇ Çʿ伺À¸·Î À̾îÁö°í ÀÖ½À´Ï´Ù. LED µð½ºÇ÷¹ÀÌ, ¸ðÅÍ ÄÁÆ®·Ñ·¯, ¾Ë¶÷ ½Ã½ºÅÛ µî ÷´Ü ±â´ÉÀ» °®Ãá ÀÚµ¿ ¾àǰ µð½ºÆæ¼ÀÇ °³¹ßÀº ¼±Áø±¹¿¡¼ ¾à º¹¿ëÀ» »ó±â½ÃŰ´Â µ¥ Å« µµ¿òÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÀÚµ¿ÈµÈ ¾à±¹ ½Ã½ºÅÛÀ» ÅëÇØ »ç¶÷µéÀº ¾à°ú Àç°í¸¦ ´õ Àß °ü¸®ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÚµ¿ÈµÈ ¾à±¹ ½Ã½ºÅÛÀ» µµÀÔÇÔÀ¸·Î½á ¼ºÀÎÀÇ º¹¾à ¼øÀÀµµ°¡ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ¯¼ºÀ¸·Î ÀÎÇØ ÇâÈÄ ¸î ³â µ¿¾È ÀϺ», Àεµ, Çѱ¹, Áß±¹ µî °³¹ßµµ»ó±¹¿¡¼ ÀÚµ¿ÈµÈ ¾à±¹ ½Ã½ºÅÛ µµÀÔÀÌ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
½ÅÈï±¹¿¡¼´Â ÀÇ·áºñ »ó½Â°ú ÀǾàǰ ¼ºñ½º Á¢±Ù¼º °³¼±¿¡ ´ëÇÑ ¾Ð·ÂÀ¸·Î ÀÎÇØ ÀǾàǰ °ü¸®°¡ ÇʼöÀûÀÔ´Ï´Ù. ½ÅÈï±¹ Á¤ºÎ´Â ÀǾàǰ¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» ³ôÀ̱â À§ÇØ ´Ù¾çÇÑ Àü·«À» äÅÃÇϰí ÀÖ½À´Ï´Ù. ¸¹Àº ½ÃÀå Âü¿©ÀÚµéÀº ¸¸¼º ÁúȯÀÇ ±ÞÁõ, º´¿øÀÇ ÃֽŠÀÇ·á ±â¼ú äÅà Áõ°¡, ÷´Ü ÀÇ·á ±â¼ú¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡·Î ÀÎÇØ Áß±¹, Àεµ, ¾Æ¶ø¿¡¹Ì¸®Æ®¿Í °°Àº ½ÅÈï ½ÃÀå¿¡ ÁÖ¸ñÇϰí ÀÖ½À´Ï´Ù.
¾Æ½Ã¾ÆÅÂÆò¾ç ¿Ü·¡È¯ÀÚ Áß¾ÓÁýÁᫎ ÁÖ¹® ó¸® ½ÃÀå °³¿ä
Áß±¹Àº ¾Æ½Ã¾ÆÅÂÆò¾ç¿¡¼ °¡Àå Å« ¿Ü·¡ ¼¾Æ®·² Ç®ÇÊ¸ÕÆ® ½ÃÀåÀÔ´Ï´Ù. Áß±¹ÀÇ 13Â÷ 5°³³â °èȹÀº °Ç°°ú ±â¼ú Çõ½ÅÀ» ¿ì¼±¼øÀ§¿¡ µÎ°í ÀÖ¾î ÷´Ü ÀÇ·á±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ³ëÀÎ Àα¸ÀÇ Áõ°¡¿Í ¸¸¼º ÁúȯÀÇ Áõ°¡´Â Áß±¹ÀÇ ¿Ü·¡ ¼¾Æ®·² Ç®ÇÊ¸ÕÆ® ½ÃÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¼÷·ÃµÈ ³ëµ¿·Â È®º¸, Àúºñ¿ë ¿î¿µ, ±¤È°ÇÑ »ý»ê °ø°£Àº Áß±¹¿¡ »ý»ê °øÀåÀ» º¸À¯ÇÑ ½ÃÀå ¸®´õµéÀ» ´õ¿í ²ø¾îµéÀ̰í ÀÖ½À´Ï´Ù. Áß±¹°ú ´Ù¸¥ ±¹°¡ÀÇ ÀÇ·á ½Ã½ºÅÛÀÇ Â÷ÀÌ·Î ÀÎÇØ Áß±¹¿¡¼´Â Áö¿ª ƯÀ¯ÀÇ ÀÇ·á °ú½Ç ÆÐÅÏÀÌ ¹ß»ýÇÕ´Ï´Ù. µû¶ó¼ ƯÈ÷ COVID-19 ´ëÀ¯Çà ±â°£ µ¿¾È ÀÚµ¿ ÀǾàǰ Á¶Á¦°¡ Å©°Ô Áõ°¡ÇßÀ¸¸ç, 2021³â Èij¼º â»ç º´¿øÀº Á¶Á¦ °È¸¦ À§ÇØ ·Îº¿ Á¶Á¦ ½Ã½ºÅÛÀ» µµÀÔÇÑ Ã¹ ¹øÂ° º´¿øÀÌ µÇ¾ú½À´Ï´Ù. ÀÚµ¿È ±â¼úÀº ÀÇ·á ºÐ¾ß¿¡¼µµ ³Î¸® »ç¿ëµÇ¾î ÀÚµ¿ ¾à±¹ ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. Áß±¹Àº À¯·´°ú ¹Ì±¹À¸·Î ÀǾàǰ ¿ø·á¸¦ °¡Àå ¸¹ÀÌ ¼öÃâÇÏ´Â ±¹°¡·Î, ¹è¼ÛÇÏ´Â Á¦Ç°ÀÇ Æ÷Àå°ú ¶óº§¸µ¿¡ ´ëÇÑ ÀÚµ¿È°¡ ÇÊ¿äÇÕ´Ï´Ù. Á¦Á¶ ÇöÀå°ú â°í¿¡ ÀÚµ¿ ¾à±¹ ½Ã½ºÅÛÀÌ ¼³Ä¡µÇ¾î ÀÖ½À´Ï´Ù.
Áß±¹¿¡¼´Â ¸¹Àº ½ºÅ¸Æ®¾÷µéÀÌ Á¶Á¦ ±â¼ú °³¹ß¿¡ Èû¾²°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, COBOTÀº »ê¾÷¿ë ·Îº¿¿ë ½º¸¶Æ® ½Ã½ºÅÛÀ» °³¹ß ¹× ÆÇ¸ÅÇÏ´Â ½ºÅ¸Æ®¾÷ÀÔ´Ï´Ù. Â÷¼¼´ë ½º¸¶Æ® Á¶Á¦ ·Îº¿À» °³¹ßÇÏ¿© »óǰÈÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀǾàǰ °ü¸® ½Ã½ºÅÛÀ» ÅëÇØ ÀÚµ¿À¸·Î Àç°í¸¦ º¸ÃæÇÒ ¼ö ÀÖ½À´Ï´Ù.
¾Æ½Ã¾ÆÅÂÆò¾ç ¿Ü·¡ ¼¾Æ®·² Ç®ÇÊ¸ÕÆ® ½ÃÀå ¸ÅÃâ ¹× 2030³â±îÁöÀÇ ¿¹Ãø(±Ý¾×)
¾Æ½Ã¾ÆÅÂÆò¾ç ¿Ü·¡ ¼¾Æ®·² Ç®ÇÊ¸ÕÆ® ½ÃÀå ¼¼ºÐÈ
¾Æ½Ã¾ÆÅÂÆò¾ç ¿Ü·¡ ¼¾Æ®·² Ç®ÇÊ¸ÕÆ® ½ÃÀåÀº Á¦Ç° À¯Çü, ÃÖÁ¾»ç¿ëÀÚ, ±¹°¡º°·Î ºÐ·ùµË´Ï´Ù. Á¦Ç° À¯Çüº°·Î ¾Æ½Ã¾ÆÅÂÆò¾ç ¿Ü·¡ ¼¾Æ®·² Ç®ÇÊ¸ÕÆ® ½ÃÀåÀº ÀÚµ¿ Åõ¾à ½Ã½ºÅÛ, ÀÚµ¿ Æ÷Àå ¹× ¶óº§¸µ ½Ã½ºÅÛ, ÀÚµ¿ Ź»ó Ä«¿îÅÍ, ÀÚµ¿ º¸°ü ¹× °Ë»ö ½Ã½ºÅÛ, ±âŸ·Î ºÐ·ùµÇ¸ç, 2022³â¿¡´Â ÀÚµ¿ Åõ¾à ½Ã½ºÅÛ ºÎ¹®ÀÌ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.
ÃÖÁ¾»ç¿ëÀÚº°·Î ¾Æ½Ã¾ÆÅÂÆò¾ç ¿Ü·¡ ¼¾Æ®·² Ç®ÇÊ¸ÕÆ® ½ÃÀåÀº º´¿ø ¾à±¹, ¼Ò¸Å ¾à±¹, ¿ìÆí ÁÖ¹® ¾à±¹À¸·Î ±¸ºÐµË´Ï´Ù. º´¿ø ¾à±¹ ºÎ¹®ÀÌ 2022³â °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.
±¹°¡º°·Î º¸¸é ¾Æ½Ã¾ÆÅÂÆò¾ç ¿Ü·¡ ¼¾Æ®·² Ç®ÇÊ¸ÕÆ® ½ÃÀåÀº Áß±¹, ÀϺ», Àεµ, È£ÁÖ, Çѱ¹, ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾çÀ¸·Î ±¸ºÐµÇ¸ç, 2022³â ¾Æ½Ã¾ÆÅÂÆò¾ç ¿Ü·¡ ¼¾Æ®·² Ç®ÇÊ¸ÕÆ® ½ÃÀå Á¡À¯À²Àº Áß±¹ÀÌ µ¶Â÷ÁöÇß½À´Ï´Ù.
Becton Dickinson and Co, Capsa Solutions, LLC, Cardinal Health Inc, McKesson Corp, and Omnicell Inc´Â ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¿Ü·¡ ¼¾Æ®·² Ç®ÇÊ¸ÕÆ® ½ÃÀå¿¡¼ »ç¾÷À» ¿î¿µÇÏ´Â ÁÖ¿ä ±â¾÷ÀÔ´Ï´Ù.
The Asia Pacific outpatient central fulfillment market was valued at US$ 50.60 million in 2022 and is expected to reach US$ 126.44 million by 2030; it is estimated to record a CAGR of 12.1% from 2022 to 2030.
Rising Aging Population and Emerging Markets Boosts Asia Pacific Outpatient Central Fulfillment Market
The aging population is a key to advancements in the healthcare sector. Thus, the growing aging population is anticipated to serve vital growth opportunity for the pharmacy. According to the United Nations World Population Prospects 2022 report, the elderly population is projected to increase from 10% of the total population in 2022 to 16% of the total population by 2050. The rapidly growing aging population indicates an exponential rise in demand for elderly care and medicines in the coming years. An upsurge in life expectancy worldwide has also led to the need for more digital and automated systems for adult care. The development of automatic medicine dispensers has served beneficially in developed regions. Advanced features such as an LED display, a motor controller, and an alarm system help people with medication reminders. Automated pharmacy systems would enable them to keep track of their medicine and stocks better. Further, implementing automated pharmacy systems has triggered adult medication adherence. With such features, the adoption of automated pharmacy systems is expected to grow in developing countries such as Japan, India, South Korea, and China in the coming years.
Pharmaceutical management is essential in developing countries owing to rising healthcare costs and pressure to improve access to pharmaceutical services. To ease access to drugs, governments of developing countries are adopting various strategies. Most market players focus on emerging markets such as China, India, and the UAE due to the surging prevalence of chronic diseases, rising adoption of the latest medical technologies in hospitals, and increasing awareness about advanced medical technologies.
Asia Pacific Outpatient Central Fulfillment Market Overview
China is the largest market for outpatient central fulfillment in Asia Pacific. The 13th Five-Year Plan of China that prioritized health and innovation has augmented demand for advanced medical devices. Moreover, the rising geriatric population and increasing chronic health conditions contribute to the outpatient central fulfillment market in this country. The availability of skilled laborers, low cost of operations, and massive space for production have further attracted the market leaders to have their production plants in China. Differences between the healthcare systems in China and other countries result in region-specific patterns of medical malpractice in China. Thus, the country has seen a significant rise in automated pharmaceutical dispensing, especially during the COVID-19 pandemic. In 2021, the Hospital of Changsha in the Hunan province was the first to install robotic pharmacy dispensing systems to enhance drug dispensing. Automation technologies are also widely used in the healthcare sector, leveraging demand for automated pharmacy systems. China is the largest exporter of active pharmaceutical ingredients to Western countries, requiring automation for the packaging and labeling of the products to be shipped. Production sites and warehouses have automated pharmacy systems installed in the manufacturing site.
Many startups in China are engaged in developing technologies for dispensing medicines. For instance, COBOT is a startup company that develops and markets smart systems for industrial robots. It has developed and commercialized a next-generation, smart medicine-dispensing robot. It can also automatically replenish stocks through a drug management system.
Asia Pacific Outpatient Central Fulfillment Market Revenue and Forecast to 2030 (US$ Million)
Asia Pacific Outpatient Central Fulfillment Market Segmentation
The Asia Pacific outpatient central fulfillment market is segmented based on product type, end user, and country. Based on product type, the Asia Pacific outpatient central fulfillment market is segmented into automated medication dispensing systems, automated packaging and labelling systems, automated tabletop counters, automated storage and retrieval systems, and others. The automated medication dispensing systems segment held the largest market share in 2022.
In terms of end user, the Asia Pacific outpatient central fulfillment market is segmented into hospital pharmacies, retail pharmacies, and mail-order pharmacies. The hospital pharmacies segment held the largest market share in 2022.
Based on country, the Asia Pacific outpatient central fulfillment market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific outpatient central fulfillment market share in 2022.
Becton Dickinson and Co; Capsa Solutions, LLC; Cardinal Health Inc, McKesson Corp; and Omnicell Inc are some of the leading players operating in the Asia Pacific outpatient central fulfillment market.